CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...